Eurofarma
Andressa Grecco Franco Simonagio is a highly experienced professional in the field of regulatory affairs, currently serving as the Global Regulatory Affairs Manager for New Products at Eurofarma since December 2009. With a robust background that includes various roles at Eurofarma, Andressa has managed teams responsible for the development, registration, and lifecycle management of pharmaceutical products in compliance with regulatory requirements across more than 20 countries. Prior experience includes a production internship at Daiichi Sankyo and a scientific internship at the Universidade de São Paulo, where Andressa conducted research in biochemistry. Educational qualifications include a degree in Pharmacy-Biochemistry from USP, a specialization in Sanitary Regulation of Biological and Biotechnological Products from WHO/PAHO, and an unfinished Master's degree in Biotechnology from USP.
Eurofarma
5 followers
Since its establishment in 1972, Eurofarma has been operating in the health industry, producing and marketing products and services to improve people's quality of life. Focused on generating shared value, it operates in the areas of Prescription, Nos-Prescription, Generics, Hospital and Oncology. It offers over 700 products, over 2,000 SKUs and serves 42 medical specialties. In Brazil, it covers 100 therapeutic classes, which represent 70% of prescriptions in the entire market. Operating in 20 countries, with manufacturing facilities in Brazil and industrial parks in six other Latin American countries, it generated net sales of R$ 7.1 billion in 2021, a growth of 23% compared to the previous year, and employs more than 8,100 people.